Get the Weekly Intelligence Brief — top committee picks every Sunday.

BCRX vs BFLY

BioCryst Pharmaceuticals, Inc. vs Butterfly Network, Inc. — AI-powered side-by-side comparison
BCRX
BioCryst Pharmaceuticals, Inc.
55
Watch
VS
BFLY
Butterfly Network, Inc.
67
Buy
MetricBCRXBFLY
AI Score 55 67
Price $10.35 $9.36
P/E Ratio -7.19× -32.38×
ROE -221.4% -39.3%
Revenue Growth YoY
Gross Margin 23.5% 51.1%
Debt / Equity -0.90× 0.10×
Dividend Yield 0.0% 0.0%
RSI (14) 75.0 66.4
Beta 0.554 2.084
Expected Upside

AI Committee View

Current Innellis committee reasoning for BCRX versus BFLY.
BFLY leads by 12 points.

BFLY scores 67/100 (Buy) versus BCRX at 55/100 (Watch).

BCRX Committee View
33% agreement
6 analysts

The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 68.7% yoy -- genuine top-line momentum. Risk Analyst remains cautious — high leverage (debt-to-equity 2.09) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Revenue growing 68.7% YoY -- genuine top-line momentum — Growth
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • Price-to-book of 13.9x prices in significant intangible value — Value
  • ROE of only -328.8% -- cheap may mean cheap for a reason — Value
  • Debt-to-equity of 2.09 adds balance-sheet risk to the value case — Value
BFLY Committee View
67% agreement
6 analysts

The primary driver is revenue growing 28.1% yoy -- genuine top-line momentum. The main limiting factor is roe of only -38.4% -- cheap may mean cheap for a reason. The committee is constructive but not yet at full conviction.

Bull Case
  • Revenue growing 28.1% YoY -- genuine top-line momentum — Growth
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • ROE of only -38.4% -- cheap may mean cheap for a reason — Value
  • Bollinger bandwidth of 52.6% signals elevated volatility — Risk
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BCRX Full Analysis BFLY Full Analysis